Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on our patented DNA delivery technologies and other therapeutic approaches.

RECENT NEWS

August 7, 2018 Vical Reports Second Quarter 2018 Financial and Operational Results
July 19, 2018 Vical Announces Review of Potential Strategic Transactions

August 7, 2018
Vical Reports Second Quarter 2018 Financial and Operational Results

July 19, 2018
Vical Announces Review of Potential Strategic Transactions

EVENTS & PRESENTATIONS

May 3, 2018 Vical Incorporated 1Q18 Financial Results Conference Call View the Webcast
March 15, 2018 Vical Incorporated 4Q17 Financial Results Conference Call View the Webcast

May 3, 2018
Vical Incorporated 1Q18 Financial Results Conference Call

March 15, 2018
Vical Incorporated 4Q17 Financial Results Conference Call

PRODUCT PIPELINE

Privacy Policy
Terms of Use
Site Map

P. 858 646 1100 10390 Pacific Center Court, San Diego, California 92121

This link to a non-Vical website is provided as a resource. Vical assumes no responsibility for content not provided by Vical, or for practices or standards of any non-Vical websites.